文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

与原发性脑出血部位相关的 10 年内卒中复发、残疾、痴呆和费用风险:基于人群的研究。

Ten-year risks of recurrent stroke, disability, dementia and cost in relation to site of primary intracerebral haemorrhage: population-based study.

机构信息

Centre for Prevention of Stroke and Dementia, University of Oxford, Oxford, Oxfordshire, UK.

Centre for Prevention of Stroke and Dementia, University of Oxford, Oxford, Oxfordshire, UK

出版信息

J Neurol Neurosurg Psychiatry. 2020 Jun;91(6):580-585. doi: 10.1136/jnnp-2019-322663. Epub 2020 Mar 12.


DOI:10.1136/jnnp-2019-322663
PMID:32165376
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7279204/
Abstract

BACKGROUND: Patients with primary intracerebral haemorrhage (ICH) are at increased long-term risks of recurrent stroke and other comorbidities. However, available estimates come predominantly from hospital-based studies with relatively short follow-up. Moreover, there are also uncertainties about the influence of ICH location on risks of recurrent stroke, disability, dementia and quality of life. METHODS: In a population-based study (Oxford Vascular Study/2002-2018) of patients with a first ICH with follow-up to 10 years, we determined the long-term risks of recurrent stroke, disability, quality of life, dementia and hospital care costs stratified by haematoma location. RESULTS: Of 255 cases with primary ICH (mean/SD age 75.5/13.1), 109 (42.7%) had lobar ICH, 144 (56.5%) non-lobar ICH and 2 (0.8%) had uncertain location. Annual rates of recurrent ICH were higher after lobar versus non-lobar ICH (lobar=4.0%, 2.7-7.2 vs 1.1%, 0.3-2.8; p=0.02). Moreover, cumulative rate of dementia was also higher for lobar versus non-lobar ICH (n/% lobar=20/36.4% vs 16/20.8%, p=0.047), and there was a higher proportion of disability at 5 years in survivors (15/60.0% vs 9/31.0%, p=0.03). The 10-year quality-adjusted life years (QALYs) were also lower after lobar versus non-lobar ICH (2.9 vs 3.8 for non-lobar, p=0.04). Overall, the mean 10-year censor-adjusted costs were £19 292, with over 80% of costs due to inpatient hospital admission costs, which did not vary by haematoma location (p=0.90). CONCLUSION: Compared with non-lobar ICH, the substantially higher 10-year risks of recurrent stroke, dementia and lower QALYs after lobar ICH highlight the need for more effective prevention for this patient group.

摘要

背景:原发性脑出血(ICH)患者长期存在复发性中风和其他合并症的风险增加。然而,现有评估主要来自于随访时间相对较短的基于医院的研究。此外,ICH 位置对复发性中风、残疾、痴呆和生活质量风险的影响也存在不确定性。

方法:在一项基于人群的研究(牛津血管研究/2002-2018 年)中,我们对首次 ICH 患者进行了长达 10 年的随访,根据血肿位置对复发性中风、残疾、生活质量、痴呆和住院护理费用的长期风险进行了分层。

结果:在 255 例原发性 ICH 患者中(平均/标准差年龄 75.5/13.1),109 例(42.7%)为皮质下ICH,144 例(56.5%)为非皮质下 ICH,2 例(0.8%)为位置不确定。皮质下 ICH 后复发性 ICH 的年发生率高于非皮质下 ICH(皮质下=4.0%,2.7-7.2% vs 1.1%,0.3-2.8%;p=0.02)。此外,皮质下 ICH 的痴呆累积发生率也高于非皮质下 ICH(皮质下 20/36.4%,非皮质下 16/20.8%,p=0.047),且幸存者在 5 年内残疾比例更高(皮质下 15/60.0%,非皮质下 9/31.0%,p=0.03)。皮质下 ICH 后的 10 年质量调整生命年(QALYs)也低于非皮质下 ICH(皮质下 2.9,非皮质下 3.8,p=0.04)。总体而言,10 年平均 censored-adjusted 成本为 19292 英镑,其中超过 80%的成本归因于住院治疗费用,这与血肿位置无关(p=0.90)。

结论:与非皮质下 ICH 相比,皮质下 ICH 后 10 年复发性中风、痴呆风险显著增加,QALYs 降低,这突出表明需要为这一患者群体制定更有效的预防措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab23/7279204/8b4ef55b1372/jnnp-2019-322663f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab23/7279204/06ccdf7c032b/jnnp-2019-322663f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab23/7279204/8b4ef55b1372/jnnp-2019-322663f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab23/7279204/06ccdf7c032b/jnnp-2019-322663f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab23/7279204/8b4ef55b1372/jnnp-2019-322663f02.jpg

相似文献

[1]
Ten-year risks of recurrent stroke, disability, dementia and cost in relation to site of primary intracerebral haemorrhage: population-based study.

J Neurol Neurosurg Psychiatry. 2020-3-12

[2]
Risks of recurrent stroke and all serious vascular events after spontaneous intracerebral haemorrhage: pooled analyses of two population-based studies.

Lancet Neurol. 2021-6

[3]
The risk of recurrent stroke after intracerebral haemorrhage.

J Neurol Neurosurg Psychiatry. 2007-8

[4]
Association Between Blood Pressure Control and Risk of Recurrent Intracerebral Hemorrhage.

JAMA. 2015-9-1

[5]
Dementia is strongly associated with 90-day mortality in lobar cerebral amyloid angiopathy related intra-cerebral haemorrhage.

J Neurol Sci. 2012-8-9

[6]
Recurrent stroke after lobar and deep intracerebral hemorrhage: a hospital-based cohort study.

Cerebrovasc Dis. 2011-8-31

[7]
Influence of intracerebral hemorrhage location on incidence, characteristics, and outcome: population-based study.

Stroke. 2015-2

[8]
Assessment of Incidence and Risk Factors of Intracerebral Hemorrhage Among Participants in the Framingham Heart Study Between 1948 and 2016.

JAMA Neurol. 2020-10-1

[9]
Longer term stroke risk in intracerebral haemorrhage survivors.

J Neurol Neurosurg Psychiatry. 2020-8

[10]
Major Cardiovascular Events After Spontaneous Intracerebral Hemorrhage by Hematoma Location.

JAMA Netw Open. 2023-4-3

引用本文的文献

[1]
Hemorrhagic Coagulation Disorders and Ischemic Stroke: How to Reconcile Both?

Neurol Int. 2023-11-30

[2]
The impact of antiplatelet drugs on recurrent stroke in patients with intracerebral hemorrhage.

Heliyon. 2023-11-3

[3]
Association of Prior Intracerebral Hemorrhage With Major Adverse Cardiovascular Events.

JAMA Netw Open. 2022-10-3

[4]
Association of Natriuretic Peptide With Adverse Outcomes and Disease Severity After Intracerebral Hemorrhage: A Systematic Review.

Front Neurol. 2021-11-15

[5]
Validity of Simple Algorithms to Identify Recurrence of Intracerebral Hemorrhage in Two Danish Nationwide Registries.

Clin Epidemiol. 2021-10-9

[6]
Stroke Prevention After Intracerebral Hemorrhage: Where Are We Now?

Curr Cardiol Rep. 2021-10-1

[7]
Risks of recurrent stroke and all serious vascular events after spontaneous intracerebral haemorrhage: pooled analyses of two population-based studies.

Lancet Neurol. 2021-6

[8]
Acute intracerebral haemorrhage: diagnosis and management.

Pract Neurol. 2020-12-7

本文引用的文献

[1]
Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial.

Lancet. 2019-5-22

[2]
Five-Year Risk of Major Ischemic and Hemorrhagic Events After Intracerebral Hemorrhage.

Stroke. 2019-5

[3]
Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study.

Lancet Neurol. 2019-2-12

[4]
Hypertension and intracerebral hemorrhage recurrence among white, black, and Hispanic individuals.

Neurology. 2018-6-6

[5]
Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds: A meta-analysis.

Neurology. 2017-8-22

[6]
Dementia risk after spontaneous intracerebral haemorrhage: a prospective cohort study.

Lancet Neurol. 2016-4-28

[7]
Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial.

Trials. 2015-9-4

[8]
Association Between Blood Pressure Control and Risk of Recurrent Intracerebral Hemorrhage.

JAMA. 2015-9-1

[9]
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.

Stroke. 2015-5-28

[10]
European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage.

Int J Stroke. 2014-10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索